APPENDICES. A systematic review and economic model of the ...

Study Intervention Participants Outcomes
Additional outcomes
Services Use by Children and
Adolescents–Parent Interview: use
and dose of medication, use of
specialty mental health services, use
of special education services
Total withdrawals = 20 (at 14 months)
Arm 1 = 8
Arm 2 = 3
Arm 3 = 3
Arm 4 = 6
Total withdrawals = 39 (93%) (24 months)
Age
8.5 years (mean); 0.8 years (SD)
Arm 3
Medication management plus
Behavioural treatment
Integration of all treatment
components in Arms 1 and 2 (except
bibliotherapy), such that information
is shared amongst all involved in
decision-making
(Administered by
therapist–consultant, counselloraides)
IQ
100.9 (mean)
Co-morbid disorders
Anxiety disorder: n = 194 (33.5%)
CD: n = 83 (14.3%)
ODD: n = 231 (39.9%)
Affective disorder: n = 22 (3.8%)
Tic disorder: Total: n = 63 (10.9%)
Mania/hypomania: n = 13 (2.2%)
Other co-morbid conditions (e.g. bulimia, enuresis): n = 1 (0.2%)
Arm 4
Standard community care
List of community mental health
resources given to those without
treatment provider; otherwise
referred back for treatment
(Individuals administering medication
not reported)
© Queen’s Printer and Controller of HMSO 2006. All rights reserved.
Diagnostic subtypes
All children met criteria for ADHD Combined Type
Health Technology Assessment 2006; Vol. 10: No. 23
Additional information
Previous medication:
Total: n = 178 (31%): Arm 1: n = 46 (32%), Arm 2: n = 38 (26%),
Arm 3: n = 44 (30%), Arm 4: n = 50 (34%)
No significant differences were found across sites (p = 0.0001).
Participants in the trial were not to have been in receipt of any
neuroleptic medication in previous 6 months
363